REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q3 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,490 | -15.9% | 2,764 | +2.2% | 0.00% | – |
| Q2 2023 | $54,061 | -2.0% | 2,705 | -7.3% | 0.00% | – |
| Q1 2023 | $55,150 | -61.7% | 2,917 | -53.9% | 0.00% | – |
| Q4 2022 | $143,870 | -13.9% | 6,324 | +0.0% | 0.00% | – |
| Q3 2022 | $167,000 | +13.6% | 6,322 | +5.4% | 0.00% | – |
| Q2 2022 | $147,000 | -31.6% | 5,998 | -7.6% | 0.00% | – |
| Q1 2022 | $215,000 | +5.4% | 6,491 | +3.7% | 0.00% | – |
| Q4 2021 | $204,000 | -8.5% | 6,262 | +17.5% | 0.00% | – |
| Q3 2021 | $223,000 | -65.1% | 5,328 | -67.6% | 0.00% | -100.0% |
| Q2 2021 | $639,000 | +23.1% | 16,444 | +8.0% | 0.00% | 0.0% |
| Q1 2021 | $519,000 | +79.0% | 15,227 | +138.7% | 0.00% | 0.0% |
| Q4 2020 | $290,000 | +544.4% | 6,378 | +295.7% | 0.00% | – |
| Q3 2020 | $45,000 | -8.2% | 1,612 | +22.2% | 0.00% | – |
| Q2 2020 | $49,000 | +2.1% | 1,319 | -9.7% | 0.00% | – |
| Q1 2020 | $48,000 | – | 1,461 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |